Understanding the viral interactome in the mammalian gut for novel therapeutic discovery

MRC · United Kingdom government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

December 31, 2026
Response Due
Active
Status

Opportunity Overview

The human intestinal microbiota is estimated to exceed 1014 cells and is composed of hundreds of bacterial species. The total genomic information of this microbiota is >100-times more than the human genome. Invading enteric viruses such as norovirus, the leading cause of acute viral gastroenteritis worldwide, must negotiate this complex mixture to start infecting the host. Whilst some organisms within this mixture of microbiota have been hypothesised to be protective against viral infection, others are thought to promote infection. Thus, the microbial composition is believed to dictate pathogenesis.

This project aims to study this hypothesis and the complex "interactome", the interaction between the gut microbiota and incoming viral pathogens. In doing so we will answer questions such as, which bacterial species do enteric viruses latch onto in a healthy microbiota, what are the molecular bases of these interactions and how do they protect against infection? Understanding these questions could help discover future therapies to tackle gastroenteric virus infections.

This interdisciplinary project includes groups at Universities of Leeds and Newcastle and will use cutting edge methodologies on imaging with fluorescently-labelled viruses, structural biology, in vitro mammalian model systems, and nano-scale sorting. This PhD is highly collaborative and will require interaction with researchers in the Astbury Centre of Structural Biology, Faculties of Biological Science and Faculty of Medicine at the University of Leeds and Imaging leaders at the University of Newcastle. The research spans the groups of Dr Morgan Herod (virologist), Dr Caroline Chilton (bacteriologist, clinical microbiology) and Dr Andrew Filby (nano-imaging and cytometry). The project will also benefit from existing collaborators in structural and molecular biology and cell biology, and provide training in interdisciplinary science to give the student a unique set of skills and expertise...

This is one of 1,831 active United Kingdom Research Development opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch Development
PublishedSeptember 30, 2022
Procurement stageActive solicitation
Response dueDecember 31, 2026
StatusOpen — accepting responses
Official sourceView original notice
Last verifiedAugust 12, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Related Opportunities in United Kingdom

Rotation year
Title of project: Evaluation of the quantitative accuracy and radiation dosimetry of an advanced pre-clinical multipinhole SPECT/CT theranostic imag
Discerning MCT1s role in chromatin remodelling and metabolomics changes in cancer progression
Leveraging real world data to characterise the long term impact of COVID-19
Bacterial antibiotic resistance: structure, mechanism and inhibition of ABC transporters responsible for drug efflux and cell wall biogenesis.
Characterising the role of TEX12 in centrosome and cilia development
Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2)
Iron and immunity

See every United Kingdom Research Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research Development intelligence report in your inbox

A personalized report on United Kingdom Research Development opportunities, emailed in 5-10 minutes. One per month, no account needed.